| Year ended 31 December | |||
| 2024 | 2023 | ||
Continuing operations | Note | US$’000 | US$’000 |
Revenue | 4 | ||
Cost of sales | ( | ( | |
Gross profit | |||
Research and development expenses | 5 | ( | ( |
Sales and marketing expenses | ( | ( | |
General and administration expenses | ( | ( | |
of which expected credit loss | 18 | ( | |
Other operating (expense)/income | 6 | ( | ( |
of which expected credit loss | 18 | ( | |
Operating (loss) | ( | ( | |
Finance income | 9 | ||
Finance expense | 9 | ( | ( |
Loss from joint venture | 16 | ( | |
Loss before tax | ( | ( | |
Income tax expense | 10 | ( | ( |
Net (loss) | ( | ( | |
| Other comprehensive (expense)/income | |||
| Items that may be reclassified subsequently to profit or loss: | |||
Currency exchange (loss)/gain on translation of foreign operations | ( | ||
( | |||
| Items that will not be reclassified to profit or loss: | |||
Currency exchange remeasurements of defined benefit obligation | 25 | ( | ( |
Related income tax credit | |||
( | ( | ||
Other comprehensive income/(expense) | ( | ||
Total comprehensive loss | ( | ( | |
Loss per share (US$ cents) | 11 | ||
Basic | ( | ( | |
Diluted | ( | ( |
| As at 31 December | |||
| 2024 | 2023 | ||
| Note | US$’000 | US$’000 | |
| Assets | |||
Cash and cash equivalents | 17 | ||
Trade and other receivables | 18 | ||
Contract assets | 4 | ||
Inventories | 19 | ||
Income tax receivables | 10 | ||
Warrant payment to customer | 4 | ||
Other current assets | 20 | ||
Total current assets | |||
Goodwill | 12 | ||
Other intangible assets | 13 | ||
Property and equipment – owned | 14 | ||
Property and equipment – leased | 15 | ||
Other investments | |||
Trade and other receivables | 18 | ||
Contract assets | 4 | ||
Other assets | 20 | ||
Warrant payment to customer | 4 | ||
Deferred tax assets | 10 | ||
Total non-current assets | |||
Total assets | |||
| Liabilities and equity | |||
Trade and other payables | 21 | ||
Contract liabilities | 4 | ||
Income taxes payable | 10 | ||
Lease liabilities | 15 | ||
Loans and borrowings | 22 | ||
Total current liabilities | |||
Trade and other payables | 21 | ||
Contract liabilities | 4 | ||
Warrant liability | 4 | ||
Lease liabilities | 15 | ||
Loans and borrowings | 22 | ||
Deferred tax liabilities | 10 | ||
Total non-current liabilities | |||
Total liabilities | |||
Ordinary shares | 26 | ||
Share premium account | 26 | ||
Merger reserve | 26 | ( | ( |
Share-based payment reserve | 26 | ||
Currency translation reserve | 26 | ( | ( |
Convertible bonds | 26 | ||
Retained earnings | |||
Total equity | |||
Total liabilities and equity |
| Year ended 31 December | |||
Restated 1 | |||
| 2024 | 2023 | ||
| Note | US$’000 | US$’000 | |
| Cash flows from operating activities | |||
Net (loss) | ( | ( | |
| Non-cash items within operating profit: | |||
– Amortisation of intangible assets | 13 | ||
– Depreciation of property and equipment – owned | 14 | ||
– Depreciation of property and equipment – leased | 15 | ||
– Share-based compensation expense | 27 | ||
– Currency translation (gain)/loss on intercompany balances | ( | ||
– Disposal of PPE loss | |||
Deferred cash rights | |||
Finance income | 9 | ( | ( |
Finance expense | 9 | ||
Loss from joint venture | 16 | ||
Income tax expense | |||
Cash generated from operations before changes in working capital | |||
| Changes in working capital: | |||
(Increase) in trade and other receivables and warrant payment to customer | ( | ( | |
Decrease in inventories | |||
(Increase) in contract assets | ( | ( | |
Increase in trade and other payables, R&D credit, accruals and warrant liability | |||
Increase/(decrease) in contract liabilities | ( | ||
Cash generated from operations | |||
Income taxes paid (net) | ( | ( | |
Cash inflow from operating activities | |||
| Cash flows from investing activities | |||
Purchase of intangible assets | 13 | ( | ( |
Purchase of property and equipment | 14 | ( | ( |
Capitalised development expenditure | ( | ( | |
Investment in joint venture | 16 | ( | |
Purchase of businesses, net of acquired cash | ( | ||
Purchase price adjustment for Open Five acquisition | |||
Interest received | |||
Cash outflow from investing activities | ( | ( | |
| Cash flows from financing activities | |||
Issue of ordinary shares | 26 | ||
Interest paid | ( | ( | |
Lease payments | 15 | ( | ( |
Issue of convertible debt | 22 | ||
Drawdown of loans and borrowings | 22 | ||
Transaction costs related to convertible debt | ( | ||
Repayment of loans and borrowings | ( | ( | |
Cash inflow/(outflow) from financing activities | ( | ||
Net decrease in cash and cash equivalents | ( | ||
Cash and cash equivalents at the beginning of the year | |||
Currency translation (loss)/gain on cash and cash equivalents | ( | ||
Cash and cash equivalents at the end of the year | 17 |
| Ordinary | Share | Share-based | Currency | ||||||
| share | premium | Merger | payment | translation | Convertible | Retained | |||
| capital | account | reserve | reserve | reserve | bonds | earnings | Total | ||
| Note | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | |
As at 1 January 2023 | ( | ( | |||||||
Net loss | ( | ( | |||||||
| Other comprehensive | |||||||||
expense | ( | ||||||||
Total comprehensive loss | ( | ( | |||||||
| Settlement of share awards: | |||||||||
– Issue of ordinary shares | 26 | ||||||||
| – Transfer of cumulative | |||||||||
compensation expense on settled awards | 26 | ( | |||||||
| – Share-based | |||||||||
compensation expense for the year | 27 | ||||||||
Other changes in equity | |||||||||
As at 31 December 2023 | ( | ( | |||||||
Net loss for the year | ( | ( | |||||||
| Other comprehensive | |||||||||
expense | ( | ( | ( | ||||||
Total comprehensive loss for the year | ( | ( | ( | ||||||
| Settlement of share awards: | |||||||||
– Issue of ordinary shares | 26 | ||||||||
| – Transfer of cumulative | |||||||||
compensation expense on settled awards | 26 | ( | |||||||
| Share-based compensation | |||||||||
expense for the year | 27 | ||||||||
| Recognition of convertible | |||||||||
bond | 22 | ||||||||
Other changes in equity | ( | ||||||||
As at | ( | ( |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Revenue by type: | ||
IP and NRE | 214,453 | 100,676 |
IP reseller licensing | 41,118 | — |
IP and NRE – JV | 3,227 | 66,891 |
Silicon and royalties | 48,792 | 154,157 |
307,590 | 321,724 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Revenue by region: | ||
North America | 123,770 | 82,160 |
China | 54,546 | 190,376 |
APAC (ex-China) | 81,178 | 33,459 |
EMEA | 48,096 | 15,729 |
307,590 | 321,724 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| APAC (ex-China) based | ||
customer | 37,916 | — |
EMEA based customer | 31,295 | — |
China based customer | — | 78,226 |
China based customer | — | 66,891 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
At the beginning of the year | 65,173 | 58,534 |
Revenue accrued in the period | 75,360 | 61,182 |
Accrued revenue invoiced in the period | (43,577) | (50,681) |
Expected credit loss | (1,261) | (3,862) |
At the end of the year | 95,695 | 65,173 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
At the beginning of the year | 50,106 | 91,733 |
Revenue recognised in the period | (45,448) | (90,346) |
Revenue deferred in the period | 57,659 | 48,743 |
Currency translation differences | — | (24) |
At the end of the year | 62,317 | 50,106 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
Capitalised contract costs | 3,914 | 1,920 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Research and development | ||
costs incurred | 166,385 | 131,441 |
| Research and development | ||
expenditure credits | (7,673) | (6,999) |
Development costs capitalised 1 | (61,600) | (46,226) |
Total | 97,112 | 78,216 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
Acquisition-related costs | (236) | (831) |
Compensation element of Banias Labs deferred cash | ||
rights (note 30) | (7,618) | (8,352) |
Leadership reorganisation | (748) | — |
| Compensation element payable | ||
for Precise-ITC (note 30) | (6,215) | — |
| Share-based compensation | ||
expense (note 27) | (27,896) | (40,691) |
Currency translation gain/(loss) | 2,022 | (2,983) |
| Impairment of accounts | ||
| receivable and contract assets | ||
related to a customer | (9,000) | — |
Other operating (expense) | (49,691) | (52,857) |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
Wages and salaries | 115,318 | 84,784 |
Social security costs | 2,674 | 2,033 |
| Defined contribution pension | ||
costs | 5,035 | 4,115 |
| Share-based compensation | ||
expense | 27,896 | 40,691 |
Total | 150,923 | 131,623 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| Number | Number | |
| Research and development/ | ||
engineering | 808 | 675 |
General and administration | 66 | 55 |
Sales and marketing | 33 | 28 |
Total | 758 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| Number | Number | |
| Research and development/ | ||
engineering | 891 | 741 |
General and administration | 68 | 58 |
Sales and marketing | 32 | 30 |
Total | 991 | 829 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Audit of the financial | ||
statements | 3,838 | 3,472 |
| Audit-related assurance | ||
services | 422 | 268 |
4,260 | 3,740 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Finance income | ||
Interest income from contracts with customers | ||
| containing significant financing | ||
components | 340 | 275 |
Interest on bank deposits | 2,688 | 3,173 |
Interest on lease deposits | 60 | — |
IIA interest | 104 | — |
Warrants income | 6,205 | — |
9,397 | 3,448 | |
| Finance expense | ||
Bank charges | (1,283) | (65) |
Lease interest | (1,725) | (1,581) |
Term Loan interest | (19,275) | (16,489) |
| Term Loan interest capitalised | ||
to the balance sheet | 13,378 | 9,534 |
| Convertible bonds related | ||
expenses | (392) | — |
Interest under IAS 19 | (210) | (61) |
IIA interest | — | (174) |
(9,507) | (8,836) | |
Net finance expense | (110) | (5,388) |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Current tax | ||
UK corporation tax | 79 | (2,642) |
Adjustments to prior periods | (607) | 3,167 |
Overseas tax | 12,053 | 126 |
Total current tax | 11,525 | 651 |
| Deferred tax | ||
Origination and reversal of timing differences | (1,940) | 10,881 |
Total deferred tax | (1,940) | 10,881 |
Income tax expense | 9,585 | 11,532 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
Loss before tax | (32,934) | (39,470) |
| Loss before tax at the UK | ||
| corporation tax rate of 25% | ||
(2023: 23.52%) | (8,234) | (9,283) |
| Effects of: | ||
Share-based compensation | 4,524 | 7, 267 |
| Expenses not deductible for tax | ||
purposes | 3,186 | 3,171 |
| (Over)/under accrual of prior | ||
year provision | (607) | 3,167 |
Different tax rates applied in overseas jurisdictions | 1,054 | 667 |
Share of joint venture’s loss | — | 3,465 |
| Movement in unrecognised | ||
deferred tax assets | 8,614 | 2,146 |
Future tax rate change | (46) | — |
Other tax items | 1,094 | 932 |
Income tax expense | 9,585 | 11,532 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
At the beginning of the year | 20,859 | 11,110 |
Charge to profit or loss | (1,940) | 10,881 |
Credit to OCI | (126) | (409) |
Currency translation differences | (4) | (2) |
Other | — | (721) |
At the end of the year | 18,789 | 20,859 |
| Year ended 31 December | |||
| 2024 | 2023 | ||
| US$’000 | US$’000 | ||
Accelerated capital allowances | 14,794 | 5,720 | |
Leases | (301) | (334) | |
Intangibles | 24,693 | 22,429 | |
Non-capital loss | (9,837) | (7,19 | 3) |
Undeducted R&D expenditures | (6,240) | 1,001 | |
| Allowance for expected | |||
credit loss | (2,385) | — | |
Other temporary differences | (1,935) | (764) | |
Total | 18,789 | 20,859 | |
| Year ended 31 December | ||
| (US$ thousands except number of | ||
shares) | 2024 | 2023 |
| Numerator: | ||
Net loss for the year | (42,519) | (51,002) |
| Denominator: | ||
Weighted average number of ordinary shares for basic loss | ||
per share | 735,053,019 | 705,550,299 |
Weighted average number of ordinary shares for diluted loss | ||
per share | 735,053,019 | 705,550,299 |
| Basic loss per share | ||
(US$ cents) | (5.78) | ( 7.23) |
| Diluted loss per share | ||
(US$ cents) | (5.78) | ( 7.23) |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Carrying amount | ||
At the beginning of the year | 309,199 | 309,199 |
At the end of the year | 309,199 | 309,199 |
| Purchased | Internally | Developed | Customer | RISC-V | ||
| IP | developed IP | technology | relationships | licences | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | |
| Cost | ||||||
As at 1 January 2023 | 48,481 | 4,255 | 83,900 | 25,700 | 5,200 | 167,536 |
Additions | 1,825 | 54,539 | — | — | — | 56,364 |
| Re-classify to property | ||||||
and equipment | (1,162) | — | — | — | — | (1,162) |
Re-classification of intangibles | (2,947) | 2,947 | — | — | — | — |
As at 31 December 2023 | 46,197 | 61,741 | 83,900 | 25,700 | 5,200 | 222,738 |
Re-classify to PPE | — | (1,598) | — | — | — | (1,598) |
| Re-classification within | ||||||
Intangibles | 800 | (800) | — | — | — | — |
Additions | 1,038 | 74,978 | — | — | — | 76,016 |
As at 31 December 2024 | 48,035 | 134,321 | 83,900 | 25,700 | 5,200 | 297,156 |
| Accumulated amortisation | ||||||
As at 1 January 2023 | 5,069 | — | — | 714 | 347 | 6,130 |
Amortisation charge for the year | 10,112 | — | — | 2,142 | 1,040 | 13,294 |
As at 31 December 2023 | 15,181 | — | — | 2,856 | 1,387 | 19,424 |
Amortisation charge for the year | 10,902 | 406 | — | 2,142 | 1,040 | 14,490 |
As at 31 December 2024 | 26,083 | 406 | — | 4,998 | 2,427 | 33,914 |
| Carrying amount | ||||||
As at 31 December 2023 | 31,016 | 61,741 | 83,900 | 22,844 | 3,813 | 203,314 |
As at 31 December 2024 | 21,952 | 133,915 | 83,900 | 20,702 | 2,773 | 263,242 |
| Computer and | |||||
| laboratory | Furniture | Leasehold | Mask sets | ||
| equipment | and fixtures | improvements | and prototypes | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | |
| Cost | |||||
As at 1 January 2023 | 14,496 | 458 | 1,923 | — | 16,877 |
Additions | 15,395 | 824 | 2,349 | — | 18,568 |
Re-classify from intangible assets | 1,162 | — | — | — | 1,162 |
As at 31 December 2023 | 31,053 | 1,282 | 4,272 | — | 36,607 |
Re-classify within PPE | (5,577) | — | — | 5,577 | — |
Re-classification from Intangibles | 723 | — | — | 875 | 1,598 |
Additions | 8,063 | 2,806 | 5,006 | 17,604 | 33,479 |
Disposals | (1) | — | (11) | (4,415) | (4,427) |
As at 31 December 2024 | 34,261 | 4,088 | 9,267 | 19,641 | 67,257 |
| Accumulated depreciation | |||||
As at 1 January 2023 | 2,740 | 98 | 618 | — | 3,456 |
Depreciation charge for the year | 10,143 | 259 | 810 | — | 11,212 |
Depreciation charged to the P&L then capitalised | 1,285 | — | — | — | 1,285 |
As at 31 December 2023 | 14,168 | 357 | 1,428 | — | 15,953 |
Re-classify within PPE | (726) | — | — | 726 | — |
Depreciation charge for the year | 10,724 | 465 | 2,524 | 436 | 14,149 |
Depreciation charged to the P&L then capitalised | 1,276 | — | — | — | 1,276 |
Disposals | (1) | — | (4) | — | (5) |
Currency translation differences | 15 | — | — | — | 15 |
As at 31 December 2024 | 25,456 | 822 | 3,948 | 1,162 | 31,388 |
| Carrying amount | |||||
As at 31 December 2023 | 16,885 | 925 | 2,844 | — | 20,654 |
As at 31 December 2024 | 8,805 | 3,266 | 5,319 | 18,479 | 35,869 |
| Buildings | Equipment | Total | |
| US$’000 | US$’000 | US$’000 | |
| Cost | |||
As at 1 January 2023 | 15,306 | 5,498 | 20,804 |
Additions | 5,265 | 608 | 5,873 |
Disposals | (551) | — | (551) |
Currency translation differences | (3) | — | (3) |
As at 31 December 2023 | 20,017 | 6,106 | 26,123 |
Additions | 7,807 | 644 | 8,451 |
Disposals | (1,967) | — | (1,967) |
Currency translation differences | (10) | — | (10) |
As at 31 December 2024 | 25,847 | 6,750 | 32,597 |
| Accumulated depreciation | |||
As at 1 January 2023 | 3,468 | 2,783 | 6,251 |
Depreciation charge for the year | 3,006 | 1,606 | 4,612 |
Currency translation differences | (2) | — | (2) |
As at 31 December 2023 | 6,472 | 4,389 | 10,861 |
Depreciation charge for the year | 4,013 | 1,535 | 5,548 |
Disposals | (1,804) | — | (1,804) |
Currency translation differences | (5) | — | (5) |
As at 31 December 2024 | 8,676 | 5,924 | 14,600 |
| Carrying amount | |||
As at 31 December 2023 | 13,545 | 1,717 | 15,262 |
As at 31 December 2024 | 17,171 | 826 | 17,997 |
| US$’000 | |
As at 1 January 2023 | 14,933 |
Additions | 5,385 |
Interest expense | 1,581 |
Lease payments | (4,740) |
Currency translation differences | (479) |
As at 31 December 2023 | 16,680 |
Additions | 8,066 |
Disposals | — |
Interest expense | 1,725 |
Lease payments | (6,642) |
Currency translation differences | (114) |
Termination | (102) |
As at 31 December 2024 | 19,613 |
| As at 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
Current | 3,834 | 3,953 |
Non-current | 15,779 | 12,727 |
Total lease liabilities | 19,613 | 16,680 |
| As at 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
Expense relating to short-term leases and low-value lease expense | 730 | 716 |
Expense relating to variable lease payments not included in lease liabilities | — | — |
730 | 716 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Cash flow from financing activities | ||
Lease payments included in lease liabilities | 6,642 | 4,740 |
| Cash flow from operating activities | ||
Variable lease payments not included in lease liabilities | — | — |
Lease payments on short-term leases and leases of low-value assets | 730 | 716 |
Total cash outflow on lease payments | 7,372 | 5,456 |
| US$’000 | |
| Carrying amount | |
As at 1 January 2023 | — |
Additional investment | 14,730 |
Loss from joint venture | (14,730) |
As at 31 December 2023 | — |
Additional investment | — |
Loss from joint venture | — |
As at 31 December 2024 | — |
| As at 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
Current assets | 28,067 | 23,766 |
Property and equipment | 3,922 | 5,043 |
Intangible assets | 33,583 | 53,774 |
Other non-current assets | 1,456 | 2,176 |
Current liabilities | 44,085 | 34,411 |
Non-current liabilities | 11,193 | 24,588 |
| Included in the above amounts | ||
| are: | ||
Cash and cash equivalents | 5,224 | 13,700 |
| Current financial liabilities | ||
(excluding trade payables) | 580 | — |
| Non-current financial liabilities | ||
(excluding trade payables) | — | — |
Net assets (100%) | 11,750 | 25,759 |
| Group share of net assets | ||
(35.15%) | 4,130 | 10,948 |
| Share of losses of joint venture | ||
recognised as a liability | — | — |
Share of unrealised profits on IP licences to joint venture not recognised | — | 11,910 |
Carrying amount of liability in joint venture | — | — |
| As at 31 December | |||
| 2024 | 2023 | ||
| US$’000 | US$’000 | ||
Revenue | 6,380 | 19,826 | |
Loss from continuing operations | (41,987) | (35,930) | |
Included in loss from continuing operations are: | |||
Depreciation and amortisation | (21,313) | (20,730) | |
Interest expense | (1,393) | (2,171) | |
Other comprehensive income | — | — | |
| Total comprehensive expense | |||
(100%) | (41,987) | (35,930) | |
| Group share of total | |||
| comprehensive expense | |||
| (42.5% until 15 September | |||
202 | 4, 35.15% thereafter) | (16,682) | (15,270) |
| Reversal of share of unrealised | |||
| profits on IP licences to joint | |||
venture | 16,682 | 540 | |
Loss from joint venture | — | (14,730) |
| As at 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
Cash at bank and in hand | 162,159 | 101,291 |
Short-term deposits | 18,000 | — |
| Total cash and cash | ||
equivalents | 180,159 | 101,291 |
| As at 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Current | ||
Trade receivables from contracts with customers | 78,903 | 49,214 |
| Less: Allowance for expected | ||
credit losses | (10,107) | (5,635) |
Trade receivables – net | 68,796 | 43,579 |
Restricted cash | 5,798 | 17, 8 4 3 |
Other receivables | 6,707 | 16,667 |
Total current | 81,301 | 78,089 |
| Non-current | ||
Restricted cash | 626 | 6,392 |
Other receivables | 1,380 | — |
Total non-current | 2,006 | 6,392 |
Total trade and other receivables | 83,307 | 84,481 |
| As at 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
Finished goods | 1,371 | 4,248 |
Work in progress | 4,486 | 5,737 |
Raw materials | 132 | 1,637 |
Total inventories | 5,989 | 11,622 |
| As at 31 December | |||
| 2024 | 2023 | ||
| US$’000 | US$’000 | ||
| Current | |||
Prepayments | 7,898 | 17,09 | 4 |
Capitalised contract costs | 3,914 | 1,923 | |
Total current | 11,812 | 19,017 | |
| Non-current | |||
Prepayments | 775 | — | |
Total non-current | 775 | — | |
Total other assets | 12,587 | 19,017 |
| As at 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Current | ||
Trade payables | 32,588 | 18,098 |
Accrued expenses 1 | 27,524 | 33,553 |
Social security and other taxes | 992 | 195 |
Other payables | 15,702 | 17, 4 39 |
Total current | 76,806 | 69,285 |
| Non-current | ||
Other payables | 132 | 1,775 |
Total non-current | 132 | 1,775 |
Total trade and other payables | 76,938 | 71,060 |
| As at 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Current | ||
Term Loan | 9,375 | 5,625 |
Total current loans and borrowings | 9,375 | 5,625 |
| Non-current | ||
Revolving Credit Facility | 125,000 | 125,000 |
Term Loan | 103,281 | 88,125 |
Convertible Loan | 112,847 | — |
Israel Innovation Authority | 1,522 | 1,625 |
Total non-current loans and borrowings | 342,650 | 214,750 |
Total loans and borrowings | 352,025 | 220,375 |
| Loans and | Warrant | Interest | Lease | ||
| borrowings | liability | payable | liabilities | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | |
As at 1 January 2023 | 210,201 | — | 2,484 | 14,933 | 227,618 |
Financing cash inflow/(outflow) | 10,000 | — | (18,390) | (4,740) | (13,130) |
Currency translation differences | 174 | — | — | (40) | 134 |
Other movements | — | — | 16,053 | 6,527 | 22,580 |
As at 31 December 2023 | 220,375 | — | 147 | 16,680 | 237, 202 |
Financing cash inflow/(outflow) 2 | 166,288 | — | (19,227) | (6,642) | 140,419 |
Less: equity component related to convertible bond | (34,051) | — | — | — | (34,051) |
Financing cash inflows related to liabilities | 132,237 | — | (19,227) | (6,642) | 106,368 |
| Non-cash-related items: | |||||
Unpaid transaction costs relating to convertible bonds | (681) | — | — | — | (681) |
Other movements¹ | 94 | — | 19,542 | 10,081 | 29,717 |
Currency translation differences | — | — | — | (114) | (114) |
Initial recognition of warrant liability | — | 13,671 | — | — | 13,671 |
As at 31 December 2024 | 352,025 | 13,671 | 462 | 20,005 | 386,163 |
| As at 31 December 2024 | |||
| Carrying amount | |||
| Amortised | Fair | ||
| cost | value | ||
| US$’000 | US$’000 | ||
| Financial assets | |||
Cash and cash equivalents | 180,159 | 180,159 | |
Trade and other receivables | 95,894 | 95,894 | |
Contract assets | 95,695 | 95,695 | |
Warrant payment to customer | 19,848 | 19,848 | |
Total financial assets | 391,596 | 391,596 | |
| Financial liabilities | |||
Trade and other payables | (76,938) | (76,938) | |
Lease liabilities | (19,613) | (19,613) | |
Loans and borrowings | (352,025) | (331,213) | |
Total financial liabilities | (448,576) | (427,76 | 4) |
| As at 31 December 2023 | ||
| Carrying amount | ||
| Amortised | Fair | |
| cost | value | |
| US$’000 | US$’000 | |
| Financial assets | ||
Cash and cash equivalents | 101,291 | 101,291 |
Trade and other receivables | 103,498 | 103,498 |
Contract assets | 65,173 | 65,173 |
Total financial assets | 269,962 | 269,962 |
| Financial liabilities | ||
Trade and other payables | (71,060) | (71,060) |
Lease liabilities | (16,680) | (16,680) |
Loans and borrowings | (220,375) | (220,375) |
Total financial liabilities | (308,115) | (308,115) |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Contingent consideration | ||
At the beginning of the year | — | (5,000) |
Settlements | — | 5,000 |
At the end of the year | — | — |
As at 31 December 2024 | As at 31 December 2023 | |||||
| Weighted | Gross carrying | Loss | Weighted | Gross carrying | Loss | |
| average | amount | allowance | average | amount | allowance | |
| loss rate | US$’000 | US$’000 | loss rate | US$’000 | US$’000 | |
Start-up company based in developing country | 21% | 47,504 | 9,903 | 12% | 45,311 | 5,620 |
Other start-up companies | 13% | 22,268 | 2,858 | 0% | 21,658 | 85 |
Established company based in developing country | 10% | 11,588 | 1,209 | 25% | 11,261 | 2,772 |
Other established companies | 1% | 98,361 | 1,260 | 3% | 40,019 | 1,020 |
179,721 | 15,230 | 118,249 | 9,497 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
At the beginning of the year | 9,497 | 2,184 |
Net remeasurement of loss allowance | 8,005 | 7,3 37 |
Written-off in the year | (2,272) | — |
Foreign exchange difference | — | (24) |
At the end of the year | 15,230 | 9,497 |
| As at 31 December 2024 | ||||
| Interest bearing | ||||
| Non-interest | ||||
| Floating rate | Fixed rate | bearing | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | |
Cash and cash equivalents | 107,661 | 18,000 | 54,498 | 180,159 |
Trade and other receivables and other assets | — | — | 95,894 | 95,894 |
Contract assets | — | — | 95,695 | 95,695 |
Total financial assets | 107,661 | 18,000 | 246,087 | 371,748 |
Trade and other payables | — | — | (76,938) | (76,938) |
Lease liabilities | — | (19,613) | — | (19,613) |
Loans and borrowings | (239,179) | (112,846) | — | (352,025) |
Total financial liabilities | (239,179) | (132,459) | (76,938) | (448,576) |
| As at 31 December 2023 | ||||
| Interest bearing | ||||
| Non-interest | ||||
| Floating rate | Fixed rate | bearing | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | |
Cash and cash equivalents | 65,443 | 1,457 | 34,391 | 101,291 |
Trade and other receivables and other assets | — | — | 103,498 | 103,498 |
Contract assets | — | — | 65,173 | 65,173 |
Total financial assets | 65,443 | 1,457 | 203,062 | 269,962 |
Trade and other payables | — | — | (71,060) | (71,060) |
Lease liabilities | — | — | (16,680) | (16,680) |
Loans and borrowings | (220,375) | — | — | (220,375) |
Total financial liabilities | (220,375) | — | (87,740) | (308,115) |
| As at 31 December 2024 | |||||||||
| CAD | GBP | ILS | INR | RMB | TWD | EUR | USD | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | |
| Cash | |||||||||
| and cash | |||||||||
equivalents | 596 | 3,373 | 315 | 1,955 | 2,386 | 34 | 253 | 171,247 | 180,159 |
| Trade | |||||||||
and other receivables | |||||||||
and other assets | — | 459 | 950 | 3,186 | 54 | — | 94 | 91,151 | 95,894 |
| Contract | |||||||||
assets | — | — | — | — | — | — | — | 95,695 | 95,695 |
| Trade | |||||||||
and other payables | (1,716) | (6,991) | (4,993) | (8,541) | (166) | — | (210) | (54,321) | (76,938) |
| Lease | |||||||||
liabilities | (9,513) | — | (527) | (4,163) | (114) | — | — | (5,296) | (19,613) |
Loans and borrowings | — | — | (1,522) | — | — | — | — | (350,503) | (352,025) |
(10,633) | (3,159) | (5,777) | (7,563) | 2,160 | 34 | 137 | (52,027) | (76,828) |
| As at 31 December 2023 | |||||||||
| CAD | GBP | ILS | INR | RMB | TWD | EUR | USD | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | US$’000 | |
| Cash | |||||||||
| and cash | |||||||||
equivalents | 632 | 41,957 | 133 | 473 | 2,756 | 210 | — | 55,130 | 101,291 |
| Trade | |||||||||
and other receivables | |||||||||
and other assets | 20,376 | 902 | 596 | 1,055 | 6,211 | 72 | — | 74,286 | 103,498 |
| Contract | |||||||||
assets | — | — | — | — | 66 | — | — | 65,107 | 65,173 |
| Trade | |||||||||
and other payables | (26,829) | (4,969) | (2,266) | (3,954) | (393) | (21) | — | (32,628) | (71,060) |
| Lease | |||||||||
liabilities | (14,949) | — | (832) | (890) | (9) | — | — | — | (16,680) |
Loans and borrowings | — | — | (1,625) | — | — | — | — | (218,750) | (220,375) |
(20,770) | 37, 890 | (3,994) | (3,316) | 8,631 | 261 | — | (56,855) | (38,153) |
| As at 31 December | ||
| 2024 | 2023 | |
| Foreign currency | US$’000 | US$’000 |
CAD | (1,020)/1,020 | (834)/834 |
GBP | 463/(463) | 778/(778) |
ILS | 627/(627) | 498/(498) |
INR | — | 26/(26) |
RMB | 283/(283) | 632/(632) |
USD | 1,295/(1,295) | 899/(899) |
| As at 31 December 2024 | ||||
| Due within | Due between | Due > | ||
| 1 year | 1 and 5 years | 5 years | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | |
Trade and other payables | 76,806 | 132 | — | 76,938 |
Lease liabilities | 5,767 | 17,469 | 2,312 | 25,548 |
Loans and borrowings | 32,102 | 316,797 | 150,925 | 499,824 |
114,675 | 334,398 | 153,237 | 602,310 |
| As at 31 December 2023 | ||||
| Due within | Due between | Due > | ||
| 1 year | 1 and 5 years | 5 years | Total | |
| US$’000 | US$’000 | US$’000 | US$’000 | |
Trade and other payables | 69,285 | 1,775 | — | 71,060 |
Lease liabilities | 3,953 | 7,660 | 5,067 | 16,680 |
Loans and borrowings | 5,625 | 214,750 | — | 220,375 |
78,863 | 224,185 | 5,067 | 308,115 |
| As at 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
Total equity | 489,753 | 468,448 |
Loans and borrowings | 352,025 | 220,375 |
Cash and cash equivalents | (180,159) | (101,291) |
Net debt | 171,866 | 119,084 |
Lease liabilities | 19,613 | 16,680 |
Total capital | 298,274 | 332,684 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
At the beginning of the year | 2,476 | 821 |
| Recognised in profit or loss: | ||
Current service cost | 920 | 489 |
Interest expense | 210 | 60 |
Recognised in other comprehensive income: | ||
Experience adjustments | 18 | 472 |
| Change in Financial | ||
| Assumptions in relation | ||
to prior year | 406 | — |
| Change in Financial | ||
| Assumptions in relation | ||
to current year | 487 | 735 |
Benefits paid by employer | (191) | (59) |
Currency translation differences | (108) | (42) |
At the end of the year | 4,218 | 2,476 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Staff attrition rate – age less | ||
than 30 years | 10% p.a. | 10% p.a. |
Staff attrition rate – 31-44 years | 5% p.a. | 5% p.a. |
| Staff attrition rate – 45 years | ||
and above | 3% p.a. | 3% p.a. |
Mortality rate | IALM 2012-14 | IALM 2012-14 |
| Rate of increase in salaries | ||
year 1 | 20.0% p.a. | 22.0% p.a. |
| Rate of increase in salaries | ||
year 2 | 15% p.a. | 15% p.a. |
| Rate of increase in salaries year | ||
3 onwards | 10% p.a. | 10% p.a. |
Discount rate | 7.1% p.a. | 7.4% p.a. |
| Nominal | ||
| Number | value | |
| of shares | US$’000 | |
As at 1 January 2023 | 695,068,200 | 9,751 |
Shares issued under employee share schemes | 20,446,367 | 260 |
As at 31 December 2023 | 715,514,567 | 10,011 |
Shares issued under employee share schemes | 35,624,639 | 440 |
As at 31 December 2024 | 751,139,206 | 10,451 |
Year ended 31 December 2024 | Year ended 31 December 2023 | |||
| Weighted | Weighted | |||
| average | average | |||
| Number | exercise price 1 | Number | exercise price 1 | |
| of awards | (US$) | of awards | (US$) | |
Outstanding at the beginning of the year | 86,263,963 | 0.842 | 85,692,153 | 0.712 |
Granted | 30,158,836 | 1.548 | 24,810,455 | 1.387 |
Exercised or vested | (34,585,080) | 1.083 | (20,446,367) | 0.808 |
Forfeited | (4,113,184) | 1.302 | (3,792,278) | 1.002 |
Outstanding at the end of the year | 77,724,535 | 0.980 | 86,263,963 | 0.842 |
Vested at the end of the year | 39,703,803 | 0.455 | 43,669,961 | 0.339 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Payable: | ||
Within one year | 42,659 | 32,602 |
Between one and two years | 45,678 | 11,132 |
Between two and five years | 43,902 | 1,369 |
After more than five years | — | — |
Total | 132,239 | 45,103 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
Short-term employee benefits | 7,998 | 5,898 |
Post-employment benefits | 137 | 162 |
Termination benefits | 817 | 344 |
Share-based payments | 6,882 | 4,774 |
15,834 | 11,178 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Transactions | ||
Revenue from companies on which a Director is the chairman of the board 1 | 33 | 429 |
Revenue from VeriSilicon | 2,056 | — |
Revenue from WiseWave, a joint venture, where there is common directorship | 3,227 | 66,879 |
Operating expenses from a company on which a Director is a director | (3,278) | (133) |
Costs capitalised as intangible assets from a company on which a Director is a director | (1,000) | (1,000) |
1,038 | 66,175 |
| Year ended 31 December | ||
| 2024 | 2023 | |
| US$’000 | US$’000 | |
| Balances | ||
Accounts receivable from a company on which a Director is the chairman of the board 1 | 2,760 | 1,650 |
Accounts receivable from VeriSilicon | 200 | — |
Accounts receivable from WiseWave, a joint venture, where there is common directorship | 19,603 | 6,364 |
Contract asset from companies on which a Director is the chairman of the board 1 | 1,720 | 2,567 |
Contract asset from WiseWave, a joint venture, where there is common directorship | 14,361 | 40,785 |
Prepaid expenses with a company on which a Director is a director | 67 | 67 |
38,711 | 51,433 | |
Contract liabilities from VeriSilicon | (2,566) | — |
Contract liabilities from WiseWave, a joint venture, where there is common directorship | (326) | — |
Accrued liabilities with a company on which a Director is a director | (500) | (600) |
(3,392) | (600) |